Stay updated on Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.

Latest updates to the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check20 days agoChange DetectedThe page has been updated to version 3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) and an older revision tag (v3.0.2) have been removed.SummaryDifference0.4%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; the Back to Top element was removed as a minor UI change.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated to include a new publication from PubMed regarding the safety of tralokinumab in patients with moderate-to-severe atopic dermatitis, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference3%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of topics related to drug safety and counterfeit drugs. Notably, the revision version has been updated from v2.16.12 to v3.0.0.SummaryDifference5%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.